El Cerrito, CA, United States of America

Tsze Tsang

This inventor holds 33 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 3 EPO patents. Top assignees: Exelixis, Inc., Chevron Research & Technology Company, University of California. Active years: 1991-2025.

USPTO Granted Patents = 33 (Patent Applications = 5)

% Patents Active = 75.8

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 4.1

ph-index = 6

Forward Citations = 164(Granted Patents)

Company Filing History:

Chevron Research & Technology Company

patents

5 out of 15,988

University of California

patents

4. 4 out of 10

Symphony Evolution, Inc.

Imperial Chemical Industries Limited

Rascal Therapeutics, Inc.

patent

9. 1 out of 1

Rescue Therapeutics, Inc.

patent

10. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1991-2025

Loading Chart...

Areas of Expertise:

Cancer Treatment

Phthalazine Derivatives

MEK Inhibitors

Quinazoline Modulators

Receptor-Type Kinase Inhibitors

Benzoxazepines

Azetidines

Protein Kinase Modulators

Fungicidal Compounds

Herbicides

Anaplastic Lymphoma Kinase

Fungicidal Imidazole

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12227482 - Compounds and compositions for the treatment of cancer (2025-02-18),

2. 12145925 - Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer (2024-11-19),

3. 11597699 - MEK inhibitors and methods of their use (2023-03-07),

4. 11560356 - Compounds and compositions for the treatment of cancer (2023-01-24),

5. 11072600 - Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer (2021-07-27),

6. 10640493 - Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer (2020-05-05),

7. 10266518 - Solid dosage formulations of substituted quinazoline receptor-type kinase modulators and methods of use thereof (2019-04-23),

8. 9796704 - Substituted quinazolines as receptor-type kinase inhibitors (2017-10-24),

9. 9359332 - Processes for the preparation of substituted quinazolines (2016-06-07),

10. 8697737 - Raf modulators and methods of use (2014-04-15),

11. 8658654 - Receptor-type kinase modulators and methods of use (2014-02-25),

12. 8648066 - Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture (2014-02-11),

13. 8637499 - Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture (2014-01-28),

14. 8362002 - Azetidines as MEK inhibitors for the treatment of proliferative diseases (2013-01-29),

15. 8101625 - Pyrimidinones as Casein Kinase II (CK2) modulators (2012-01-24),

Title: The Innovative Journey of Tsze Tsang

Introduction: Tsze Tsang is a renowned inventor based in El Cerrito, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Tsze Tsang holds several patents in various technological domains, including artificial intelligence, renewable energy, and biotechnology.

Career Highlights: With a career spanning over two decades, Tsze Tsang has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized the industry.

Collaborations: Throughout his career, Tsze Tsang has collaborated with top scientists, engineers, and researchers to bring his innovative ideas to life. His collaborative efforts have resulted in the successful development of numerous groundbreaking technologies.

Conclusion: Tsze Tsang's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in the field of technology. His contributions continue to inspire the next generation of inventors and shape the future of technological advancements.